Disease: Stomach Carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE Adrenergic modulation of AMPK‑dependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer. 30896863 2019
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE Bioinformatics analysis predicted that there is a SPRY4-IT1/miR-101-3p/AMPK axis in GC progression. 31330497 2019
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE MTDH-stimulated cancer resistance to 5-FU may be mediated through autophagy activated by the AMPK/ATG5 pathway in GC. 29635244 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE The anti-gastric cancer mechanism of BBR might be involved in AMPK-HNF4α-WNT5A signaling pathway. 30405404 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells. 30054562 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE Our results demonstrate that CAMKK2 signals in gastric cancer through AMPK activation and suggest that CAMKK2 could be a novel therapeutic target in gastric cancer. 25756516 2015
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma 		0.070 Biomarker disease BEFREE We identified HNF4α-WNT5A regulation in the cross-talk between the AMPK metabolic pathway and the WNT signaling pathway, and further identified WNT5A as a potential therapeutic target for GC. 24681952 2014